Guizhou Yibai Pharmaceutical Co.,Ltd.’s Net Profit Dropped 32.8% in First Three Quarters of 2022

Guizhou Yibai Pharmaceutical Co.,Ltd. (贵州益佰制药股份有限公司) (600594.SH) reported a net profit of 194.2 million yuan in the first three quarters of 2022, down 32.8% year-on-year.

Meanwhile, the company posted 2.1 billion yuan in revenue, down 19.4% year-on-year.

At the end of the reporting period, it had 5.9 billion yuan in total assets and 2 billion yuan in total liabilities, with a liability-to-asset ratio of 34.8%.